Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia.

International journal of molecular sciences - 13 Dec 2022

Vaiman Elena E, Shnayder Natalia A, Zhuravlev Nikita M, Petrova Marina M, Asadullin Azat R, Al-Zamil Mustafa, Garganeeva Natalia P, Shipulin German A, Cumming Paul, Nasyrova Regina F

Abstract excerpt

Antipsychotics (AP) induced prolongation of the QT interval in patients with schizophrenia (Sch) is an actual interdisciplinary problem as it increases the risk of sudden death syndrome. Long QT syndrome (LQTS) as a cardiac adverse drug reaction is a multifactorial symptomatic disorder, the development of which is influenced by modifying factors (APs' dose, duration of APs therapy, APs polytherapy, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Electrocardiography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genetic Predisposition to Disease

Share to Long QT Syndrome

Share to Schizophrenia

Source

Open in PubMed Open full text

Identifiers

PMID: 36555428
DOI: 10.3390/ijms232415786
PMCID: PMC9785058

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia.PMID 36555428Read ↗

Effect of GWAS-Identified Genetic Variants on Maximum QT Interval in Patients With Schizophrenia Receiving Antipsychotic Agents: A 24-Hour Holter ECG Study.Semantic proximity Read ↗

ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association studySemantic proximity Read ↗

Genome-wide association study of antipsychotic-induced QTc interval prolongation.Semantic proximity Read ↗

[Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms].Semantic proximity Read ↗

A molecular pathway analysis informs the genetic risk for arrhythmias during antipsychotic treatment.Semantic proximity Read ↗

Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia.Semantic proximity Read ↗

Genetics of Common Antipsychotic-Induced Adverse EffectsSemantic proximity Read ↗

Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics.Semantic proximity Read ↗

Associations of schizophrenia with arrhythmic disorders and electrocardiogram traits: an in-depth genetic exploration of population samplesSemantic proximity Read ↗

Pharmacogenetics and schizophrenia.Semantic proximity Read ↗

Pharmacogenomics of antipsychotics efficacy for schizophreniaSemantic proximity Read ↗

Pharmacogenomic and inflammatory determinants of antipsychotic-induced extrapyramidal toxicity in Egyptian patients with schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.